High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$19.7M
$19,704,706
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-10 | $51,806 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -55.7%
2026-03-10
$599,087
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -55.7%
|
2026-03-10 | $599,087 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-09 | $670,200 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -12.8%
2026-03-09
$1,356,072Largex2
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -12.8%
|
2026-03-09 | $1,356,072Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-04 | $120,700 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-04 | $702,114x2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-03 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-03 | $1,380,149Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-02 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $1,393,894Largex3 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-02-05 | $120,700 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-05 | $786,366x2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-02-04 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-04 | $1,544,820Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-02-03 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-03 | $1,522,317Largex3 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2025-12-01 | $59,356 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-12-01 | $134,375 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-01 | $1,141,925Largex4 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-11-12 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $1,410,990Largex3 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-11-11 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-11 | $1,382,600Largex3 | S | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Connaughton Bernadette
• Director
10b5-1 Sell
2025-11-10
$136,960
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2025-11-10 | $136,960 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-11-10 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-10 | $1,374,339Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Equity Compensation
|
2025-11-01 | $0 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Sell to CoverΔOwn -25.1%
2025-11-01
$277,905
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Sell to CoverΔOwn -25.1%
|
2025-11-01 | $277,905 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-10-03 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-03 | $1,380,638Largex4 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-10-02 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $1,424,083Largex5 | S | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Connaughton Bernadette
• Director
10b5-1 Sell
2025-10-01
$150,481x2
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2025-10-01 | $150,481x2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-10-01 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-01 | $1,507,024Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CFO
10b5-1 Sell
|
2025-09-22 | $173,584x2 | S | Form 4 |